RAD-140 research capsules are provided for controlled laboratory studies investigating selective androgen receptor modulator (SARM) activity, AR-targeted signaling, and tissue selectivity. For researchers asking what is RAD-140, preclinical data describes it as an orally bioavailable SARM with potent anabolic properties in experimental models. Studies examining RAD-140 benefits focus on its potential effects on muscle, bone, and targeted tissue interaction, alongside its pathway-specific selectivity. Each 100-count unit (500 mcg per capsule) is precisely measured for research consistency. For laboratory research use only — not for human consumption.
Product Details:
• Compound: RAD-140 (Testolone)
• Form: Oral capsules
• Dosage per capsule: 500mcg
• Counts available: 30, 60, 100 capsules
• Purity: >99% (HPLC Verified)
• Storage: Store in a cool, dry place away from light
Intended Use:
This compound is intended for laboratory research use only. It is not intended for human consumption, medical, or diagnostic purposes.
Related Research Studies:
- Design, synthesis, and preclinical characterization of RAD‑140 (PubMed). Describes discovery and anabolic activity of RAD‑140 with oral bioavailability in preclinical models.
- Selective AR modulator RAD‑140 inhibits growth in AR+/ER+ models (PubMed). Shows AR‑targeted action and antitumor effects in breast cancer models; evidence of AR pathway engagement.
Findings:
Preclinical/early clinical literature characterizes RAD‑140 as an orally bioavailable SARM with AR‑selective activity.
